Pin Zhang

机构：Chinese Academy of Medical Sciences & Peking Union Medical College, National Cancer Center, Zhengzhou Central Hospital · ORCID：0000-0002-7141-9541

发表论文 93 篇 · 总被引 920 次 · h-index 13

代表论文

• Dalpiciclib plus letrozole or anastrozole versus placebo plus letrozole or anastrozole as first-line treatment in patients with hormone receptor-positive, HER2-negative advanced breast cancer (DAWNA-2): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial (2023 · The Lancet Oncology · 被引 106)
• Changes of Mycoplasma pneumoniae infection in children before and after the COVID - 19 pandemic, Henan, China (2022 · Journal of Infection · 被引 22)
• Machine Learning for Early Prediction of Major Adverse Cardiovascular Events After First Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction: Retrospective Cohort Study (2023 · JMIR Formative Research · 被引 18)
• A systematic review of current status and challenges of vaccinating children against SARS-CoV-2 (2022 · Journal of Infection and Public Health · 被引 11)
• Effect of glomerular filtration rate in patients undergoing percutaneous coronary intervention: A systematic review and meta-analysis (2022 · Medicine · 被引 10)
• Prevalence of Frailty and Its Impact on Quality of Life in Older Patients With Breast Cancer: A Prospective Cross‐Sectional Study (2024 · Journal of Clinical Nursing · 被引 9)